Treatment of low-grade non-Hodgkin's lymphoma with continuous infusion of low-dose recombinant interleukin-2 in combination with the B-cell-specific monoclonal antibody CLB-CD19.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples